RSV Vaccine Protected Infants From Severe Cases, Study Finds

Name Art / 01/11/2022 / Business News

Pfizer says results are sufficient to seek approval for the shot, which could be the first deployed against the common respiratory virus

Source link

Source link

Rate this post

Category Business News Tag Cases child Demographic Health Finds general news health healthcare Healthcare/Life Sciences Immunizations infant Infant/Child/Teenage Health Infants life sciences Medical Conditions medical treatments Medical Treatments/Procedures medications PFE Pfizer Pharmaceuticals political Political/General News procedures Protected Respiratory Tract Diseases RSV Severe specialized drugs Specialized Drugs/Medications Study SYND teenage health Vaccine Vaccines WSJ-PRO-WSJ.com wsjhealth

Add your comment Cancel Reply

You must be logged in to post a comment.

Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected!!!

We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.